Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Belgium |
First Approval Date01 Jan 2002 |
100 Clinical Results associated with Labo'Life España SA
0 Patents (Medical) associated with Labo'Life España SA
100 Deals associated with Labo'Life España SA
100 Translational Medicine associated with Labo'Life España SA